Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors. | Leukemia;8 Suppl 3: S38-41, 1994. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors.

Eisenhauer, E A; Lippman, S M; Kavanagh, J J; Parades-Espinoza, M; Arnold, A; Hong, W K; Massimini, G; Schleuniger, U; Bollag, W; Holdener, E E.

Affiliation

Eisenhauer EA; NCIC Clinical Trials Group, Queen's University, Kingston, Ontario, Canada.

Leukemia ; 8 Suppl 3: S38-41, 1994.

Article in En | MEDLINE | ID: mdl-7808023

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Neoplasms Limits: Female / Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 1994 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Neoplasms Limits: Female / Humans Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 1994 Document type: Article Affiliation country: Country of publication: